Moderna’s Noubar Afeyan hopes they will have result from trial of COVID-19 vaccine in spring

Armenian-American entrepreneur, philanthropist and venture capitalist Noubar Afeyan, the co-founder and chairman of the US bio-tech company Moderna Therapeutics, hopes that they will get a result from the trial of a vaccine against the novel coronavirus (COVID-19) in spring.

Speaking during an online conference titled “COVID-19: Challenging General Fear”, Afeyan introduced information to the panelists about the vaccine created by Moderna Therapeutics, stating that currently clinical testing is underway, and they hope that they will have a positive result from the trial in spring.